Status:
COMPLETED
Comparison of the Cosmetic Outcome of Hypofractionated Versus Normofractionated IMRT in Treatment of Breast Cancer
Lead Sponsor:
Universitätsmedizin Mannheim
Conditions:
Tumors
Breast Cancer
Eligibility:
FEMALE
60+ years
Phase:
PHASE3
Brief Summary
Several multicenter studies have shown the equivalence of hypofractionated radiotherapy and normofractionated radiotherapy after breast-conserving surgery. However, the treatment in these studies was ...
Eligibility Criteria
Inclusion
- Histologically confirmed invasive or in situ breast cancer, tumor stage pTis-pT3, pN0-1a, M0
- Age ≥ 60 years
- signed informed consent from the patient
Exclusion
- Stage pN1b-PN3, pT4 and / or M1
- incomplete surgical resection
- after mastectomy of the ipsilateral or contralateral breast
- breast reconstruction with implant or expander insert
- bilateral breast cancer
- Lack of compliance or consent
- Indications for irradiation of the axillary, supraclavicular or parasternal lymph nodes
Key Trial Info
Start Date :
July 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 2 2017
Estimated Enrollment :
226 Patients enrolled
Trial Details
Trial ID
NCT01403779
Start Date
July 1 2010
End Date
February 2 2017
Last Update
November 7 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Radiotherapy University Hospital Mannheim
Mannheim, Germany, 68167